Caribou Biosciences, Inc. (CRBU)
USD 1.78
(-8.25%)
USD 1.78
(-8.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 34.47 Million | 13.85 Million | 9.59 Million | 12.36 Million | 5.78 Million |
| Cost of Revenue | 112.07 Million | 3.64 Million | 984 Thousand | 34.42 Million | 23.63 Million |
| Gross Profit | -77.59 Million | 10.21 Million | 8.61 Million | -22.06 Million | -17.84 Million |
| Operating Expenses | 150.53 Million | 120.25 Million | 76.57 Million | 48.48 Million | 40.09 Million |
| Selling, General and Administrative Expenses | 38.46 Million | 38.02 Million | 24.32 Million | 14.06 Million | 16.45 Million |
| Research and Development Expenses | 112.07 Million | 82.23 Million | 52.25 Million | 34.42 Million | 23.63 Million |
| Other Expenses | - | 7.18 Million | -1.34 Million | 514 Thousand | - |
| Cost and Expenses | 150.53 Million | 120.25 Million | 76.57 Million | 48.48 Million | 40.09 Million |
| Operating Income | -116.05 Million | -106.39 Million | -66.97 Million | -36.12 Million | -34.3 Million |
| Interest Expense | - | - | 8000.00 | 20 Thousand | 4000.00 |
| Income Tax Expense | 193 Thousand | 70 Thousand | 321 Thousand | -1.81 Million | -7.53 Million |
| Earnings before Tax | -101.87 Million | -99.35 Million | -66.6 Million | -36.12 Million | -30.96 Million |
| Net Income | -102.07 Million | -99.42 Million | -66.92 Million | -34.3 Million | -23.43 Million |
| Earnings Per Share Basic | -1.38 | -1.64 | -1.11 | -0.57 | -0.39 |
| Earnings Per Share Diluted | -1.38 | -1.64 | -1.11 | -0.57 | -0.39 |
| Weighted Average Shares Outstanding | 73.8 Million | 60.8 Million | 60.26 Million | 59.97 Million | 59.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 73.8 Million | 60.8 Million | 60.26 Million | 59.97 Million | 59.97 Million |
| Gross Margin | -2.25 | 0.74 | 0.90 | -1.78 | -3.08 |
| EBIT Margin | -3.26 | -7.67 | -7.10 | -2.79 | -5.62 |
| Profit Margin | -2.96 | -7.18 | -6.97 | -2.78 | -4.05 |
| EBITDA | -112.53 Million | -104.77 Million | -65.99 Million | -35.2 Million | -30.21 Million |
| Earnings Before Tax Margin | -3.37 | -7.68 | -6.98 | -2.92 | -5.93 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 3.46 Million | 2.42 Million | 3.55 Million | 34.47 Million | 23.66 Million | 3.75 Million |
| Cost of Revenue | 856 Thousand | 710 Thousand | 1.97 Million | 3.52 Million | 2.1 Million | 1.12 Million |
| Gross Profit | 2.6 Million | 1.71 Million | 1.58 Million | 30.95 Million | 21.55 Million | 2.62 Million |
| Operating Expenses | 46.1 Million | 48.43 Million | 39.02 Million | 147.01 Million | 38.29 Million | 36.62 Million |
| Selling, General and Administrative Expenses | 10.62 Million | 14.64 Million | 7.74 Million | - | 9.71 Million | 10.12 Million |
| Research and Development Expenses | 35.48 Million | 33.78 Million | 31.27 Million | - | 28.58 Million | 26.5 Million |
| Other Expenses | 5.9 Million | 4.76 Million | 3.13 Million | 14.18 Million | 4.63 Million | 3.32 Million |
| Cost and Expenses | 46.96 Million | 48.43 Million | 41 Million | 150.53 Million | 38.29 Million | 36.62 Million |
| Operating Income | -43.5 Million | -46 Million | -37.44 Million | -116.05 Million | -14.63 Million | -32.86 Million |
| Interest Expense | - | - | 3.07 Million | - | - | - |
| Income Tax Expense | - | -710 Thousand | 193 Thousand | 193 Thousand | -1.57 Million | -639 Thousand |
| Earnings before Tax | -37.69 Million | -41.23 Million | -34.31 Million | -101.87 Million | -10 Million | -29.51 Million |
| Net Income | -37.69 Million | -41.23 Million | -34.5 Million | -102.07 Million | -10 Million | -29.51 Million |
| Earnings Per Share Basic | -0.42 | -0.46 | -0.39 | - | -0.12 | -0.48 |
| Earnings Per Share Diluted | -0.42 | -0.46 | -0.39 | - | -0.12 | -0.48 |
| Weighted Average Shares Outstanding | 90.34 Million | 89.3 Million | 88.43 Million | 73.8 Million | 83.78 Million | 61.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 90.34 Million | 89.3 Million | 88.43 Million | 73.8 Million | 83.78 Million | 61.41 Million |
| Gross Margin | 0.75 | 0.71 | 0.45 | 0.90 | 0.91 | 0.70 |
| EBIT Margin | -12.31 | -18.94 | -9.97 | - | -0.62 | -8.76 |
| Profit Margin | -10.88 | -16.98 | -9.70 | -2.96 | -0.42 | -7.86 |
| EBITDA | -42.64 Million | -46 Million | -35.46 Million | - | -14.63 Million | -32.89 Million |
| Earnings Before Tax Margin | -12.56 | -18.94 | -10.52 | -3.37 | -0.62 | -8.75 |
300146
002050
CDG
1626
600052
3658